Codexis Inc. (NASDAQ: CDXS)
$4.5900
+0.2600 ( +5.03% ) 386.0K
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
Market Data
Open
$4.5900
Previous close
$4.3300
Volume
386.0K
Market cap
$371.08M
Day range
$4.3200 - $4.6230
52 week range
$1.8500 - $4.9100
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Nov 17, 2023 |
4 | Insider transactions | 1 | Nov 14, 2023 |